Showing results (121-130 of 206) with videos related to
Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|September 7, 2024
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trialSoumyajit Roy, Fred Saad, Yilun Sun, et al.European Urology Oncology|May 12, 2024
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized TherapyVinay Mathew Thomas, Nicolas Sayegh, Beverly Chigarira, et al.BMC Cancer|April 18, 2024
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trialAdriana M Coletta, Lea Haverbeck Simon, Kelsey Maslana, et al.JCO Precision Oncology|May 23, 2024
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMIVinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, et al.Journal of the American College of Radiology : JACR|March 13, 2026
ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma, Christopher Mejias, Rustain L Morgan, et al.JAMA Network Open|May 2, 2024
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the USVinay Mathew Thomas, Yeonjung Jo, Nishita Tripathi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate CancerUmang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.European Urology|July 7, 2020
Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate CancerUmang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al.The Oncologist|June 22, 2021
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning PlatformEdwin Lin, Andrew W Hahn, Roberto H Nussenzveig, et al.Kidney Cancer (Clifton, Va.)|September 12, 2024
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based CombinationsArshit Narang, Georges Gebrael, Yeonjung Jo, et al.Pageof 21